Cartesian Therapeutics
RNAC
#6769
Rank
C$0.66 B
Marketcap
$26.29
Share price
13.16%
Change (1 day)
-44.85%
Change (1 year)

EPS for Cartesian Therapeutics (RNAC)

EPS in 2023 (TTM): -$0.43

According to Cartesian Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.45. In 2021 the company made an earnings per share (EPS) of -$0.34 an increase over its 2020 EPS that were of -$0.96.

EPS history for Cartesian Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.43
2021-$0.34-65.22%
2020-$0.96-43.44%
2019-$1.71-58.08%
2018-$4.07-9.35%
2017-$4.49-29.16%
2016-$6.33